Reporter Unravels Why His Cancer Drug Costs So Much

newser.com/story/368385/reporter-unravels-why-his-cancer-drug-costs-so-much.html

David Armstrong has been writing about sky-high health care costs and the tactics of Big Pharma for years. His latest story in ProPublica has a far more personal angle: After being diagnosed with cancer—multiple myeloma—in 2023, he started taking a drug called Revlimid made by Celgene.…

This story appeared on newser.com, 2025-05-11 12:12:10.007000.
The Entire Business World on a Single Page. Free to Use →